Clinical Trial: Oligomeric Alpha-synuclein in Multiple System Atrophy

Study Status: Terminated
Recruit Status: Unknown status
Study Type: Observational




Official Title: Oligomeric Alpha-synuclein Levels as a Biomarker for Multiple System Atrophy

Brief Summary: The main objectives are to determine on one hand whether oligomeric alpha-synuclein levels are increased in MSA patients compared to controls and on other hand whether there is a good agreement between cerebrospinal fluid (CSF) and plasma levels.